The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetesResearch in context

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetesResearch in context

Summary: Background: A delay in reaching HbA1c targets in patients with newly-diagnosed type 2 diabetes (T2D) is associated with an increased long-term risk of developing cardiovascular diseases (CVD), a phenomenon referred to as legacy effect. Whether an early introduction of glucose-lowering drug...

Full description

Bibliographic Details
Main Authors: Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Chiara Frigé, Salvatore De Cosmo, Paolo Di Bartolo, Graziano Di Cianni, Paola Fioretto, Carlo Bruno Giorda, Roberto Pontremoli, Giuseppina Russo, Francesca Viazzi, Antonio Nicolucci
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:The Lancet Regional Health. Europe
Subjects:
AMD Annals initiative
Type 2 diabetes
Metabolic memory
Legacy effect
Cardiovascular diseases
Sodium-glucose cotransporter 2 inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776223000856

Internet

http://www.sciencedirect.com/science/article/pii/S2666776223000856

Similar Items